Why the article that led to the widespread use of hydroxychloroquine in COVID-19 should be retracted?

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Journal ID (nlm-ta): Therapie

Journal ID (iso-abbrev): Therapie

Title: Therapie

Publisher: Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.

ISSN (Print): 0040-5957

ISSN (Electronic): 1958-5578

Publication date PMC-release: 2 June 2023

Publication date (Electronic): 2 June 2023

Affiliations

[a ]Department of Intensive Care Medicine, CHR Metz-Thionville, 57530 Ars-Laquenexy, France

[b ]Media and Information Technology, Linköping University, 581 83 Norrköping, Sweden

[c ]Harbers Bik LLC, San Francisco, California, USA

[d ]Not affiliated, 67000 Strasbourg, France

[e ]University Rouen, Department of Forensic Medicine and Pathology, 76031 Rouen Cedex, France

[f ]Department of Plant Molecular Biology, Faculty of Biology and Medicine, University of Lausanne (UNIL), CH-1015 Lausanne, Switzerland

[g ]Sorbonne Université, INSERM, Institut Pierre Louis d’Epidémiologie et de Santé Publique, AP-HP, Hôpital Pitié-Salpêtrière, Département de Santé Publique, Centre de Pharmacoépidémiologie, 75231 Paris, France

[h ]Sorbonne Université, IPLESP, Hôpital St Antoine, AP-HP, 75231 Paris, France

[i ]Research Integrity Officer, School of Medicine, Université Paris-Cité, 75106 Paris, France

[j ]Service de Pharmacologie CHU de Bordeaux - Université de Bordeaux, 33600 Pessac, France

[k ]Institute of Biology, University of Neuchâtel, 2000 Neuchâtel, Switzerland

[l ]Hospital Network of Neuchâtel, University of Neuchâtel, 2000 Neuchâtel, Switzerland

[m ]Not affiliated, 06000 Nice, France

Author notes

[* ]Corresponding author: CHR Metz Thionville, 1, Allée du Château, 57530 Ars-Laquenexy, France

Article

Publisher Item ID: S0040-5957(23)00081-1

DOI: 10.1016/j.therap.2023.06.001

PMC ID: 10236894

SO-VID: 05e46c2d-9f04-40b5-88cf-31e59bd591f8

License:

Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

History

Date received : 2 May 2023

Comments

Comment on this article

scite_

Smart Citations

Citing PublicationsSupportingMentioningContrasting

View Citations

See how this article has been cited at scite.ai

scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.